Filing Flows › InspireMD (NSPR) › Q1 2026 › vs Q4 2025
InspireMD (NSPR) Q1 2026 vs Q4 2025 (quarter over quarter)
InspireMD's revenue rose $249K (+8%) from $3.1M in Q4 2025 to $3.4M in Q1 2026.
InspireMD, Q1 2026: revenue $3.4M (+122% year over year), operating margin -411.4%, net loss $13.7M, operating cash flow −$12.3M. The chart draws each line against Q4 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q4 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $3.4M | $3.1M | $249K | +8% |
| Other income, net | $289K | $323K | −$34K | -11% |
| Net loss | $13.7M | $11.8M | $1.9M | +16% |
| Costs & expenses | $17.4M | $15.2M | $2.1M | +14% |
| Operating costs | $17.4M | $15.2M | $2.1M | +14% |
| Cost of revenue | $2.7M | $2.0M | $742K | +38% |
| Research & development | $4.8M | $3.5M | $1.3M | +37% |
| Sales & marketing | $5.2M | $5.2M | −$59K | -1% |
| General & admin | $4.7M | $4.5M | $172K | +4% |
| Operating cash sources | $14.6M | $488M | −$473M | -97% |
| Depreciation | $149K | $476M | −$476M | -100% |
| Share-based compensation | $2.1M | $2.8M | −$743K | -26% |
| Cash used in operations | $12.3M | $9.3M | $3.0M | +32% |
| Net loss absorbed | $13.7M | $11.8M | $1.9M | +16% |
| Working capital & other | $902K | $476M | −$475M | -100% |
Questions
How much did InspireMD's revenue grow quarter over quarter in Q1 2026?
InspireMD's revenue rose $249K (+8%) from $3.1M in Q4 2025 to $3.4M in Q1 2026.